Treatment was initiated at 36 mg/day and patients continued with incremental raises of 18 mg/day (36 to 108 mg/day) based on meeting particular enhancement requirements with appropriate tolerability. At the final research pay a visit to, signify improve scores (LS Signify, SEM) with the investigator rating to the AISRS demonstrated that CONCERTA wa